• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在服用甲磺酸伊马替尼 65 个月的情况下,一名慢性髓性白血病患者发生多发性骨髓瘤。

Development of multiple myeloma in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate for 65 months.

机构信息

Department of Haematology, Nicosia, General Hospital, 2 Amfipoleos Street, 2025, Nicosia, Cyprus.

出版信息

Oncologist. 2009 Dec;14(12):1198-200. doi: 10.1634/theoncologist.2009-0165. Epub 2009 Dec 2.

DOI:10.1634/theoncologist.2009-0165
PMID:19955186
Abstract

The simultaneous occurrence of multiple myeloma (MM) and chronic myeloid leukemia (CML) is an extremely rare event that has been reported in only eight cases in the literature. We report here on only the third case of the development of MM in a patient with CML on treatment with imatinib mesylate, and to our knowledge, this is the first case in a patient who received imatinib as first-line treatment.

摘要

同时发生多发性骨髓瘤(MM)和慢性髓性白血病(CML)是一种极为罕见的事件,文献中仅报告了 8 例。我们在此报告的仅是第三例接受甲磺酸伊马替尼治疗的 CML 患者发生 MM 的病例,据我们所知,这是首例接受伊马替尼作为一线治疗的患者。

相似文献

1
Development of multiple myeloma in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate for 65 months.在服用甲磺酸伊马替尼 65 个月的情况下,一名慢性髓性白血病患者发生多发性骨髓瘤。
Oncologist. 2009 Dec;14(12):1198-200. doi: 10.1634/theoncologist.2009-0165. Epub 2009 Dec 2.
2
Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.一名慢性髓性白血病患者在接受甲磺酸伊马替尼治疗后发生多发性骨髓瘤。
Oncologist. 2005 Jun-Jul;10(6):457-8. doi: 10.1634/theoncologist.10-6-457.
3
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.甲磺酸伊马替尼治疗慢性髓性白血病致卡波西肉瘤 1 例
Clin Ther. 2009 Nov;31(11):2565-9. doi: 10.1016/j.clinthera.2009.11.018.
4
Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.慢性髓性白血病接受甲磺酸伊马替尼治疗后发生的多发性骨髓瘤。
Ann Hematol. 2009 Mar;88(3):281-2. doi: 10.1007/s00277-008-0597-2. Epub 2008 Aug 26.
5
Hematological and molecular response evaluation of CML patients on imatinib.伊马替尼治疗的慢性粒细胞白血病患者的血液学和分子反应评估
J Assoc Physicians India. 2007 Feb;55:109-13.
6
Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.在甲磺酸伊马替尼治疗慢性髓性白血病期间发生的急性髓性白血病,且不存在新的细胞遗传学异常。
Leuk Res. 2007 Nov;31(11):1589-92. doi: 10.1016/j.leukres.2007.01.022. Epub 2007 Mar 27.
7
Imatinib mesylate in chronic myeloid leukemia: a prospective, single arm, non-randomized study.甲磺酸伊马替尼治疗慢性粒细胞白血病:一项前瞻性、单臂、非随机研究。
J Assoc Physicians India. 2005 Apr;53:291-5.
8
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.慢性髓性白血病完全细胞遗传学缓解后与伊马替尼相关的骨髓再生障碍
J Coll Physicians Surg Pak. 2008 Mar;18(3):176-8.
9
A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.甲磺酸伊马替尼(格列卫)治疗皮肤病的综合综述。
J Drugs Dermatol. 2006 Feb;5(2):117-22.
10
Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy.一位慢性粒细胞白血病患者在接受甲磺酸伊马替尼治疗后出现大量骨髓坏死。
Haematologica. 2004 Sep;89(9):ECR32.

引用本文的文献

1
The Synchronous Diagnosis of Multiple Myeloma (MM) and Chronic Myeloid Leukemia (CML).多发性骨髓瘤(MM)与慢性髓性白血病(CML)的同步诊断
Cureus. 2024 Nov 13;16(11):e73583. doi: 10.7759/cureus.73583. eCollection 2024 Nov.
2
Targeted disruption of the fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells.通过Cas9/双sgRNA对融合基因进行靶向破坏可抑制慢性髓性白血病细胞的增殖并诱导其凋亡。
Acta Biochim Biophys Sin (Shanghai). 2024 Apr 25;56(4):525-537. doi: 10.3724/abbs.2023280.
3
Multiple myeloma in a patient with chronic myeloid leukemia: A case report.
慢性髓性白血病患者合并多发性骨髓瘤:一例报告
Oncol Lett. 2023 Apr 20;25(6):244. doi: 10.3892/ol.2023.13830. eCollection 2023 Jun.
4
An Unprecedented Case of p190 Chronic Myeloid Leukemia Diagnosed during Treatment for Multiple Myeloma: A Case Report and Review of the Literature.一例在多发性骨髓瘤治疗期间诊断出的p190慢性髓性白血病罕见病例:病例报告及文献复习
Case Rep Hematol. 2018 Oct 10;2018:7863943. doi: 10.1155/2018/7863943. eCollection 2018.
5
Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib.来那度胺、硼替佐米、地塞米松和伊马替尼同时治疗的一名患者中的免疫球蛋白D多发性骨髓瘤、浆细胞白血病和慢性粒细胞白血病
Hematol Rep. 2016 Mar 17;8(1):6295. doi: 10.4081/hr.2016.6295.
6
A case of multiple myeloma with metachronous chronic myeloid leukemia treated successfully with bortezomib, dexamethasone, and dasatinib.一例多发性骨髓瘤合并异时性慢性髓性白血病患者经硼替佐米、地塞米松和达沙替尼成功治疗。
Case Rep Oncol Med. 2014;2014:962526. doi: 10.1155/2014/962526. Epub 2014 Dec 2.
7
Unusual case of simultaneous presentation of plasma cell myeloma, chronic myelogenous leukemia, and a jak2 positive myeloproliferative disorder.同时出现浆细胞骨髓瘤、慢性粒细胞白血病和jak2阳性骨髓增殖性疾病的罕见病例。
Case Rep Hematol. 2014;2014:738428. doi: 10.1155/2014/738428. Epub 2014 Oct 15.
8
Co-existing chronic myeloid leukaemia and multiple myeloma: rapid response to lenalidomide during imatinib treatment.慢性粒细胞白血病与多发性骨髓瘤并存:伊马替尼治疗期间对来那度胺迅速起效
Int J Hematol. 2012 Apr;95(4):451-2. doi: 10.1007/s12185-012-1038-5. Epub 2012 Mar 17.
9
Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer.慢性髓性白血病合并肺浆细胞瘤,模拟原发性肺癌。
Int J Hematol. 2010 Nov;92(4):651-4. doi: 10.1007/s12185-010-0705-7. Epub 2010 Oct 22.